Essential fatty acids: Molecular and cellular basis of their anti- cancer action and clinical implications

Critical Reviews in Oncology/Hematology

Volumn 27, Issue 3, 1998, Pages 179-209

  Jiang, Wen G ^a   Bryce, Richard P ^b   Horrobin, David F ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Scotia Pharmaceuticals   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LIPID PEROXIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INVASION; CELL ADHESION; CELL MEMBRANE FLUIDITY; CYTOTOXICITY; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; LIPID PEROXIDATION; METASTASIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0032052077     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(98)00003-1     Document Type: Article

References (319)

1. [1] Sinclair HM. The diet of Canadian Indians and Eskimos. Proc Nutr Soc 1953;12:69-82.
2. [2] Lancet. Eskimo diets and diseases. Lancet 1983;i:1139-41.
3. [3] Carroll KK. Dietary factors in hormone dependent caners. In: Winick M, editor. Nutrition and Cancer. New York: Wiley, 1977.
4. [4] Karmali RA, Choi K, Otter G, et al. Eicosanoids and metastasis. Experimental aspects in Lewis lung carcinoma. Cancer Biochem Biophys 1986;9:97-104.
5. [5] Karmali RA, Marsh H, Fuchs C. Effect of ω-3 fatty acids on growth of a rat mammary tumour. J Natl Cancer Inst 1984;73:457-61.
6. [6] Begin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986;77:1053-62.
7. [7] Horrobin DF. Essential fatty acids, lipid peroxidation, and cancer. In: Horrobin DF, editor, ω-6 Essential Fatty Acids. New York: Wiley-Liss, 1990:351-78.
8. [8] Horrobin DF. Nutritional and medical importance of γ-linolenic acid. Prog Lipid Res 1992;31:163-94.
9. [9] Pandalai PK, Pilat MJ, Yamazaki K, et al. The effects of ω-3 and ω-6 fatty-acids on in-vitro prostate-cancer growth. Anticancer Res 1996;16:815-20.
10. [10] Gardiner NS, Duncan JR. Possible involvement of δ-6-desaturase in control of melanoma growth by γ-linolenic acid. Prostaglandins Leukotrienes Essent Fatty Acids 1991;42:149-53.
11. [11] Rose DP, Connolly JM, Liu XH. Effects of linoleic-acid and γ-linolenic acid on the growth and metastasis of a human breast-cancer cell-line in nude-mice and on its growth and invasive capacity in-vitro. Nutr Cancer 1995;24:33-45.
12. [12] Pritchard GA, Jones DL, Mansel RE. Lipids in breast carcinogenesis. Br J Surg 1989;76:1069-73.
13. [13] Ramchurren N, Karmali R. Effects of γ-linolenic and dihomo-γ-linolenic acids on 7,12-dimethylbenz-α-anthracene-induced mammary-tumors in rats. Prostaglandins Leukotrienes Essent Fatty Acids 1995;53:95-101.
14. [14] Jiang WG, Hiscox S, Hallett MB, et al. Inhibition of membrane ruffling and ezrin translocation by γ-linolenic acid. Int J Oncol 1996;9:279-84.
15. [15] Nicholson ML, Neoptolemos JP, Clayton HA, et al. Inhibition of experimental colorectal carcinogenesis by dietary n-6 polyunsaturated fats. Carcinogenesis 1991;11:2191-7.
16. [16] Keys SD, Murray AW, Noble BS, et al. Differential responses of human tumor-cells to polyunsaturated fatty-acids-stimulation of proliferation of a colon-tumor cell-line by docosahexaenoic acid. Int J Oncol 1995;7:927-33.
17. [17] Hrelia S, Bordoni A, Biagi P, et al. Linolenic acid supplementation can affect cancer cell-proliferation via modification of fatty-acid composition. Biochem Biophys Res Commun 1996;225:441-7.
18. [18] Hayashi Y, Fukushima S, Hirata T, et al. Anticancer activity of free γ-linolenic acid on AH-109a rat hepatoma-cells and the effect of serum-albumin on anticancer activity of γ-linolenic acid in vitro. J Pharmacobiodynam 1990;13:705-11.
19. [19] Puntis MCA, Jiang WG. Effects of γ-linolenic acid and lithium linolinate on human monocytes and hepatoma cells. In: Horrobin DF, editor. New approaches to cancer treatment: Unsaturated lipids and photodynamic therapy. New York: Churchill-Livinstone, 1994:40-67.
20. [20] Falconer JS, Ross JA, Fearon KCH, et al. Effect of eicosapentaenoic acid and other fatty-acids on the growth in-vitro of human pancreatic-cancer cell-lines. Br J Cancer 1995;69:826-32.
21. [21] Fearon KCH, Falconer JS, Ross JA, et al. An open-label phase i/ii dose-escalation study of the treatment of pancreatic-cancer using lithium-γ-linolenate. Anticancer Res 1996;16:867-74.
22. [22] Vartak S, Robbins MEC, Spector AA. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipid 1997;32:283-92.
23. [23] Dutoit PJ, Vanaswegen CH, Duplessis DJ. The effect of essential fatty-acids on growth and urokinase-type plasminogen-activator production in human prostate DU-145 cells. Prostaglandins Leukotrienes Essent Fatty Acids 1996;55:173-7.
24. [24] de Bravo M, Schinella G, Tournier H, et al. Effects of dietary γ-and α-linolenic acid on a human lung carcinoma growth in nude mice. Med Sci Res 1994;22:667-8.
25. [25] Devi MA, Das NP. Antiproliferative effect of polyunsaturated fatty-acids and interleukin-2 on normal and abnormal human-lymphocytes. Experimentia 1994; 50:489-92.
26. [26] Tisdale MJ, Beck SA. Inhibition of tumor-induced lipolysis in vitro and cachexia and tumor-growth in vivo by eicosapentaenoic acid. Biochem Pharmacol 1991;41:103-7.
27. [27] Tisdale MJ, Dhesi JK. Inhibition of weight loss by ω-3 fatty acids in an experimental cachexia model. Cancer Res 1990;50:5022-6.
28. [28] Appel MJ, Woutersen RA. Effects of dietary fish-oil (maxepa) on n-nitrosobis(2-oxopropyl)amine (bop)-induced pancreatic carcinogenesis in hamsters. Cancer Lett 1995;94:179-89.
29. [29] Minami M, Noguchi M. Effects of low-dose eicosapentaenoic acid, docosahexaenoic acid and dietary-fat on the incidence, growth and cell-kinetics of mammary carcinomas in rats. Oncology 1996;53:398-405.
30. [30] Kinoshita K, Noguchi M, Tanaka M. Effects of linoleic-acid, eicosapentaenoic acid, and docosahexaenoic acid on the growth and metastasis of MM48 mammary-tumor transplants in mice. Int J Oncology 1996;8:575-81.
31. [31] Sakaguchi M, Imray C, Davis A, et al. Effects of dietary n-3 and saturated fats on growth-rates of the human colonic-cancer cell-lines SW-620 and LS-174T in vivo. Anticancer Res 1990;10:1763-8.
32. [32] Sakaguchi M, Rowley S, Kane N, et al. Reduced tumour growth of the human colonic cancer cell lines COLO-320 and HT29 in vivo by dietary n-3 lipids. Br J Cancer 1990;62:742-7.
33. [33] Lai PBS, Ross JA, Fearon KCH, et al. Cell-cycle arrest and induction of apoptosis in pancreatic-cancer cells exposed to eicosapentaenoic acid in-vitro. Br J Cancer 1996;74:1375-83.
34. [34] Finstad HS, Koiset SO, Holme JA, et al. Effect of n-3 and n-6 fatty acids on proliferation and differenciation of promyelocytic leukemic HL-60 cells. Blood 1994;84:3799-809.
35. [35] Connolly JM, Liu XH, Rose DP. Dietary linoleic acid-stimulated human breast-cancer cell-growth and metastasis in nude-mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer 1996;25:231-40.
36. [36] Hubbard NE, Erickson KL. Role of dietary oleic-acid in linoleic acid-enhanced metastasis of a mouse mammary-tumor. Cancer Lett 1991;56:165-71.
37. [37] Lok E, Jee P, Ratnayake WMN, Scott FW, et al. The effect of different levels of dietary α-linolenic and other fatty-acids on mammary-gland ductular cell-proliferation in female Swiss-Webster mice. Cancer Lett 1995;92:229-34.
38. [38] Ritskeshoitinga J, Meijers M, Timmer WG, et al. Effects of 2 dietary-fat levels and 4 dietary linoleic-acid levels on mammary-tumor development in balb/c-MMTV mice under ad-libitum feeding conditions. Nutr Cancer 1996;25:161-72.
39. [39] Liu XH, Connolly JM, Rose DP. Eicosanoids as mediators of linoleic acid-stimulated invasion and type-IV collagenase production by a metastatic human breast-cancer cell-line. Clin Exp Metastasis 1996;14:145-52.
40. [40] Johanning GL, Lin TY. Unsaturated fatty-acid effects on human breast-cancer cell-adhesion. Nutr Cancer 1995;24:57-66.
41. [41] Earashi M, Endo Y, Obata T, et al. Effects of linoleic-acid and eicosanoid synthesis inhibitors on the growth and c-myc oncogene expression of human breast-cancer cells. Int J Oncology 1996;8:145-51.
42. [42] Rose DP, Connolly JM, Liu XH. Effects of linoleic-acid on the growth and metastasis of two human breast-cancer cell-lines in nude-mice and the invasive capacity of these cell-lines in-vitro. Cancer Res 1994;54:6557-62.
43. [43] Meterissian SH, Forse RA, Steele GD, Thomas P. Effect of membrane free fatty-acid alterations on the adhesion of human colorectal-carcinoma cells to liver macrophages and extracellular-matrix proteins. Cancer Lett 1995;89:145-52.
44. [44] Tisdale MJ. Inhibition of lipolysis and muscle protein-degradation by EPA in cancer cachexia. Nutr 1996;12:S31-3.
45. [45] Chajes V, Sattler W, Stranzl A, et al. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro. Breast Cancer Res Treat 1995;34:199-212.
46. [46] Sagar RP, Das UN. Cytotoxic action of cis-unsaturated fatty-acids on human cervical-carcinoma (HeLa) cells in-vitro. Prostaglandins Leukotrienes Essent Fatty Acids 1995;53:287-99.
47. [47] Hrboticky N, Zimmer B, Weber PC. Linolenic acid reduces the lovastatin-induced rise in arachidonic-acid and elevates cellular lipoprotein eicosapentaenoic and docosahexaenoic acid levels in Hep G2 cells. J Nutr Biochem 1996;7:465-71.
48. [48] Fukui H, Sato T, Sunamoto J. Physicochemical perturbation of α-linolenic acid-related to cell-proliferation. Bull Chem Soc (Jpn) 1994;67:2213-8.
49. [49] Kitano M, Mori S, Chen TX, et al. Lack of promoting effects of α-linolenic, linoleic or palmitic acid on urinary-bladder carcinogenesis in rats. Jpn J Cancer Res 1995;86:530-4.
50. [50] Jiang WG, Hiscox S, Hallett MB, et al. Inhibition of invasion and motility of human colon cancer cells by α-linolenic acid. Br J Cancer 1995;71:744-52.
51. [51] Jiang WG, Hiscox S, Hallett MB, et al. Regulation of the expression of E-cadherin on human cancer cells by α-linolenic acid. Cancer Res 1995;55:5043-8.
52. [52] Hudson EA, Beck SA, Tisdale MJ. Kinetics of the inhibition of tumor-growth in mice by eicosapentaenoic acid-reversal by linoleic-acid. Biochem Pharmacol 1993;45:2189-94.
53. [53] Pagliacci MC, Spinozzi F, Migliorati G, et al. Genistein inhibits tumor-cell growth in-vitro but enhances mitochondrial reduction of tetrazolium salts - a further pitfall in the use of the MTT assay for evaluating cell-growth and survival. Eur J Cancer 1993;29A:1573-7.
54. [54] Slavotinek A, Mcmillan TJ, Steel CM. Measurement of radiation survival using the MTT assay. Eur J Cancer 1994;30A:1376-82.
55. [55] Keepers YP, Pizao PE, Peters GJ, et al. Comparison of the sulforhodamine-b protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 1991;27:897-900.
56. [56] Begin ME, Das UN, Ells G. Cyto-toxic effects of essential fatty-acids (EFA) in mixed cultures of normal and malignant human-cells. Prog Lipid Res 1986;25:573-6.
57. [57] Begin ME, Sircar S, Weber JM. Differential sensitivity of tumorigenic and genetically related non-tumorigenic cells to cyto-toxic poly-unsaturated fatty-acids. Anticancer Res 1989;9:1049-52.
58. [58] Fujiwara F, Todo S, Imashuku S. Fatty-acid modification of cultured neuro-blastoma cells by γ-linolenic acid relevant to its antitumor effect. Prostaglandin Leukotriene Med 1987;30:37-49.
59. [59] Tsai WS, Nagawa H, Muto T. Differential effects of polyunsaturated fatty acids on chemosensitivity of NIH3t3 cells and its transformants. Int J Cancer 1997;70:357-61.
60. [60] de Antueno R, Elliot M, Bai M, et al. Diol lipids as novel compounds for n-6 and n-3 fatty acid delivery to cancer cells. Prostaglandins Leukotrienes Essent Fatty Acids 1997;57:191.
61. [61] de Antueno R, Bai R, Elliot M, et al. Biotransformation of diol lipids containing eicosapentaenoic and γ-linolenic acids by human pancreatic carcinoma. Proc Am Assoc Cancer Res 1997;38:62.
62. [62] Hrelia S, Jimenez JAL, Bordoni A, et al. Essential fatty-acid metabolism in cultured rat cardiomyocytes in response to either n-6 or n-3 fatty-acid supplementation. Biochem Biophys Res Commun 1995;216:11-9.
63. [63] Dormandy TL. An approach to free radicals. Lancet 1983;ii:1010-4.
64. [64] Cheeseman KH, Burton GW, Ingold KV, et al. Lipid peroxidation and lipid antioxidation in normal and tumour cells. Toxicol Pathol 1984;12:235-9.
65. [65] Horrobin DF. Loss of δ-6-desaturase (D6D) activity as a key factor in ageing. Age 1981;4:139.
66. [66] Begin ME, Horrobin DF. Selected fatty-acids as possible second messengers for drug-induced cyto-toxicity. Anticancer Res 1985;5:589.
67. [67] Begin ME, Ells G, Das UN, Horrobin DF. Polyunsaturated fatty acids induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 1988;80:188-94.
68. [68] Menter DG, Onoda JM, Taylor JD, et al. Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res 1984;44:450-6.
69. [69] Das UN, Huang YS, Begin ME, et al. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad Biol Med 1987;3:9-14.
70. [70] Horrobin DF. Fatty-acid metabolism in health and disease -the role of δ-6-desaturase. Am J Clin Nutr 1993;57:S732-7.
71. [71] Hrelia S, Bordoni A, Motta P, et al. Kinetic-analysis of δ-6-desaturation in liver-microsomes - influence of δ-linoleic acid dietary supplementation to young and old rats. Prostaglandins Leukotrienes Essent Fatty Acids 1991;44:191-4.
72. [72] Huang YS, Smith RS, Redden PR, et al. Modification of liver fatty-acid metabolism in mice by n-3 and n-6 δ-6-desaturase substrates and products. Biochim Biophys Acta 1991;1082:319-27.
73. [73] Christiansen EN, Lund JS, Rortveit T, Rustan AC. Effect of dietary n-3 and n-6 fatty acids on fatty acid desaturation. Biochim Biophys Acta 1991;1082:57-62.
74. [74] Dias VC, Parsons HG. Modulation in δ-9, δ-6, and δ-5 fatty-acid desaturase activity in the human intestinal caco-2 cell-line. J Lipid Res 1995;36:552-63.
75. [75] Horrobin DF. The reversibility of cancer: relevance of cAMP, calcium, essential fatty acids and prostaglandin E1. Med Hypotheses 1980;6:469-86.
76. [76] Faas FH, Dang AQ, Pollard M, et al. Increased phospholipid fatty-acid remodeling in human and rat prostatic adenocarcinoma tissues. J Urol 1996;156:243-8.
77. [77] Grammatikos S, Harvey MJ, Subbaiah PV, et al. Loss of fatty-acid δ-6 desaturating ability in human mammary epithelial-cells that express an activated c-Ha-ras oncogene. Int J Oncol 1995;6:1039-46.
78. [78] Grammatikos SI, Subbaiah PV, Victor TA, et al. n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer 1994;70:219-29.
79. [79] Chajes V, Lanson M, Fetissof F, et al. Membrane fatty-acids of breast-carcinoma -contribution of host fatty-acids and tumor properties. Int J Cancer 1995;63:169-75.
80. [80] Cheeseman KH. Lipid peroxidation and cancer. In: Halliwell BH, Aruoma OI, editors. DNA and free radicals. Sussex, UK: Ellis Horwood, 1993:109-44.
81. [81] Cantrill RC, Ells G, Chisholm K, Horrobin DF. Concentration-dependent effect of iron on γ-linolenic acid toxicity in ZR-75-1 human breast-tumor cells in culture. Cancer Lett 1993;72:99-102.
82. [82] Minotti G, Aust SD. The role of iron in the initiation of lipid peroxidation. Chem Phys Lipid 1987;44:191-208.
83. [83] Minotti G, Aust SD. Redox cycling of iron and lipid peroxidation. Lipids 1992;27:219-26.
84. [84] Gonzalez MJ, Schemmel RA, Dugan L, et al. Dietary fish-oil inhibits human breast-carcinoma growth - a function of increased lipid-peroxidation. Lipids 1993;28:827-32.
85. [85] Takeda S, Sim PG, Horrobin DF, et al. Intracellular free fatty-acid release and lipid-peroxidation in cultured human breast-cancer cells in response to γ-linolenic acid with iron (GLA (Fe)). Int J Oncol 1992;1:759-63.
86. [86] Takeda S, Horrobin DF, Manku M, et al. Lipid-peroxidation in human breast-cancer cells in response to γ-linolenic acid and iron. Anticancer Res 1992;12:329-33.
87. [87] Ells GW, Chisholm KA, Simmons VA, Horrobin DF. Vitamin-E blocks the cytotoxic effect of γ-linolenic acid when administered as late as the time of onset of cell-death - insight into the mechanism of fatty-acid induced cytotoxicity. Cancer Lett 1996;98:207-11.
88. [88] Kokura S, Yoshikawa T, Kaneko T, et al. Efficacy of hyperthermia and polyunsaturated fatty acids on experimental carcinoma. Cancer Res 1997;57:2200-2.
89. [89] DeKock M, Lottering ML, Grobler CJS, et al. The induction of apoptosis in human cervical carcinoma (HeLa) cells by γ-linolenic acid. Prostaglandins Leukotrienes Essent Fatty Acids 1996;55:403-11.
90. [90] Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial-cells overexpressing prostaglandin-endoperoxide-synthase-2. Cell 1995;83:493-501.
91. [91] Bortuzzo C, Hanif R, Kashfi K, et al. The effect of leukotrienes-B and selected HETEs on the proliferation of colon-cancer cells. Biochim Biophys Acta 1996;1300:240-6.
92. [92] Newman MJ. Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor β is dependent on the presence of polyunsaturated fatty acids. Proc Natl Acad Sci USA 1990;87:5543-7.
93. [93] Brekke OL, Espevik T, Bardal T, et al. Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytoxicity in WEHI fibrosarcoma cells. Lipids 1992;27:161-8.
94. [94] Kasayama S, Koga M, Kouhara H, et al. Unsaturated fatty-acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth-factor family proteins. Cancer Res 1994;54:6441-5.
95. [95] Peppelenbosch MP, Tertoolen LGJ, Hage WJ, Delaat SW. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 1993;74:565-75.
96. [96] Reddy N, Everhart A, Eling T, Glasgow W. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: Stimulation of 13-HODE formation by TGF(α)/EGF. Biochem Biphys Res Commun 1997;231:111-6.
97. [97] Mollerup S, Haugen A. Differential effect of polyunsaturated fatty-acids on cell-proliferation during human epithelial invitro carcinogenesis - involvement of epidermal growth-factor receptor tyrosine kinase. Br J Cancer 1996;74:613-8.
98. [98] Bandyopadhyay GK, Imagawa W, Nandi S. Role of GTP binding proteins in the polyunsaturated fatty acid stimulated proliferation of mouse mammary epithelial cells. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:151-8.
99. [99] Guffy MM, North JA, Burns CP. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells. Cancer Res 1984;44:1863-6.
100. [100] Needs GT, Jones DL, Hughes LE. Effect of polyunsaturated fatty acids on doxorubicin sensitivity in MCF-7 cells. Br J Surg 1991;78:749.
101. [101] Kinsella JE, Black JM. Effects of polyunsaturated fatty-acids on the efficacy of antineoplastic agents toward 15178y lymphoma-cells. Biochem Pharmacol 1993;45:1881-7.
102. [102] Ferguson PJ. Cytoxic and chemomodulative effects of γ-linolenic acid (GLA) against a human squamous cell carcinoma line and multidrug resistant (MDR) and carboplastin-resistant (CPR) variants. Proc Am Assoc Cancer Res 1995;36:290.
103. [103] Plumb JA, Luo W, Kerr DJ. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. Br J Cancer 1993;67:728-33.
104. [104] Sircar S, Cai F, Begin ME, Weber JM. Transformation renders mdr cells more sensitive to polyunsaturated fatty-acids. Anticancer Res 1990;10:1783-6.
105. [105] Zijlstra JG, De Vries EGE, Muskiet FAJ, et al. Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small cell lung cancer cell lines, and on cytoxicity in the tumour cell lines. Int J Cancer 1987;40:850-6.
106. [106] Timmer-Bosscha H, Hospers GAP, Mulder MNH, et al. Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 1989;81:1069-75.
107. [107] Madhavi N, Das UN. Reversal of KB-3-1 and KB-ch(r)-8-5 tumor-cell drug-resistance by cis-unsaturated fatty-acids invitro. Med Sci Res 1994;22:689-92.
108. [108] Weber JM, Sircar S, Begin ME. Greater sensitivity of human multidrug-resistant (MDR) cancer-cells to polyunsaturated fatty-acids than their non-MDR counterparts. J Natl Cancer Inst 1994;86:638-9.
109. [109] Davies CL, Duffy PM, Macrobert AJ, et al. Localization of anthracycline accumulation in sensitive and resistant urothelial tumor-cell lines. Cancer Detect Prevent 1996;20:625-33.
110. [110] Bosanquet AG, Buriton AG, Bell PB. Ex vivo activity profile of γ-linolenic acid and cross-resistance with anthracycline, antimetabolites, alkalators, steroids, vincristine and radiosensitivity. Proc Am Assoc Cancer Res 1997;38:104.
111. [111] Atkinson TG, Barker HJ, MecklingGill KA. Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weaning Fischer 344 rats. Lipids 1997;32:293-302.
112. [112] Hopewell JW, Robbins MEC, Vandenaardweg GJMJ, et al. The modulation of radiation-induced damage to pig skin by essential fatty-acids. Br J Cancer 1993;68:1-7.
113. [113] Hopewell JW, Vandenaardweg GJMJ, Morris GM, et al. Amelioration of both early and late radiation-induced damage to pig skin by essential fatty-acids. Int J Radiat Oncol Biol Phys 1994;30:1119-25.
114. [114] Morris GM, Hopewell JW, Ross GA, et al. Trophic effects of essential fatty-acids on pig skin. Cell Prolif 1995;28:73-84.
115. [115] Tiwari RK, Mukhopadhyay B, Telang NT, Osborne MP. Modulation of gene-expression by selected fatty-acids in human breast-cancer cells. Anticancer Res 1991;11:1383-8.
116. [116] Jiang WG, Hiscox S, Bryce RP, et al. Linolenic acid (GLA) regulates the expression of nm23 and in vitro invasion of human breast cancer cells. Breast Cancer Res Treat 1996;41:282.
117. [117] Jiang WG, Hiscox S, Horrobin DF, et al. Regulation of nm23 expression by n-6 polyunsaturated fatty acids. Br J Cancer 1997;77;731-8.
118. [118] Tillotson JK, Darzynkiewicz Z, Cohen LA, Ronai Z. Effects of linoleic-acid on mammary-tumor cell-proliferation are associated with changes in p53 protein expression. Int J Oncol 1993;3:81-7.
119. [119] Hayashi T, Matesic DF, Nomata K, et al. Stimulation of cell proliferation and inhibition of gap junctional intercellular communication by linoleic acid. Cancer Lett 1997;112:103-11.
120. [120] Clark SD, Jump DB. Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr 1994;14:83-98.
121. [121] Forman BM, Chen J, Evans RM. Hydropipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator activated receptors α and δ. Proc Natl Acad Sci USA 1997;94:4312-7.
122. [122] Kliewer SA, Sundeth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator activated receptor α and γ. Proc Natl Acad Sci USA, 1997;94:4318-23.
123. [123] Krey G, Braissant O, Lhorset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997;11:779-91.
124. [124] Beck F, Plummer S, Senior PV, et al. The ontogeny of peroxisome-proliferator-activated receptor gene-expression in the mouse and rat. Proc R Soc London 1992;247:83-7.
125. [125] Alvares K, Carrillo A, Yuan PM, et al. Identification of cytosolic peroxisome proliferator binding-protein as a member of the heat-shock protein hsp70 family. Proc Natl Acad Sci USA 1990;87:5293-7.
126. [126] Zhang BW, Marcus SL, Sajjadi FG, et al. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-coa hydratase 3-hydroxyacyl-coa dehydrogenase. Proc Natl Acad Sci USA 1992;89:7541-5.
127. [127] Nunez SB, Medin JA, Braissant O, et al. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor. Mol Cell Endocrinol 1997;127:27-40.
128. [128] Pineau T, Hudgins WR, Liu L, et al. Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem Pharmacol 1996;52:659-67.
129. [129] Lehmann JM, Lenhard JM, Oliver BB, et al. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1997;272:3406-10.
130. [130] Hart IR, Goode NT, Wilson RE. Molecular aspects of the metastatic cascade. Biochim Biophys Acta 1989;989:65-84.
131. [131] Jiang WG, Puntis MCA, Hallett MB. The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment. Br J Surg 1994;81:1576-90.
132. [132] Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
133. [133] Kemler R. From cadherins to catenins. Trend Genet 1993;9:317-21.
134. [134] Jiang WG. E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 1996;83:437-46.
135. [135] Mareel M, Berx G, Vanroy F, Bracke M. Cadherin/catenin complex - a target for antiinvasive therapy. J Cell Biochem 1996;61:524-30.
136. [136] Jiang WG, Mansel RE. Progress in anti-invasion and antimetastasis research and treatment. Int J Oncol 1996;9:1013-28.
137. [137] Jiang WG, Hiscox S. Catenin, cell adhesion and beyond. Int J Oncol 1997;11:635-41.
138. [138] Rubinfeld B, Robbins P, El-Gamil M, et al. Stabilization of β-catenin by genetic defects in melanoma cells. Science 1997;275:1790-2.
139. [139] Resnik E. catenin - one player, two games. Nat Genet 1997;16:9-11.
140. -/- colo carcinoma. Science 1997;275:1784-7.
141. [141] Jiang WG, Hiscox S, Horrobin DF, et al. Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. Anticancer Res 1995;15:2569-74.
142. [142] Garrod DR. Desmosomes and hemidesmosomes. Curr Opin Cell Biol 1993;5:30-40.
143. [143] Koch PJ, Franke WW. Desmosomal cadherins, another growing multigene family of adhesion molecules. Curr Opin Cell Biol 1994;6:682-7.
144. [144] Kowalczyk AP, Stappenbeck TS, et al. Structure and function of desmosomal transmembrane core and plaque molecules. Biophys Chem 1994;50:97-112.
145. [145] Lewis JE, WahlIII JK, Sass KM, et al. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 1997;136:919-34.
146. [146] Pauli BU, Cohen SM, Alroy J, Weinstein RS. Desmosome ultrastructure and the biological behaviour of chemical carcinogen induced urinary bladder carcinomas. Cancer Res 1978;38:3276-85.
147. [147] Stein LS, Stein DWJ, Echols J, Burghardt RC. Concomitant alterations of desmosomes, adhesivess, and diffusion through gap junction channels in a rat ovarian transformation model system. Exp Cell Res 1993;207:19-32.
148. [148] Wright-Perkins S, Daniel MR, Walker C. Changes in expression of neural cell adhesion molecule and desmoplakin associated with phenotypic transitions in cloned cells lines from a non small cell lung carcinoma. Int J Oncol 1995;6:623-7.
149. [149] Natsugoe S, Sagara M, Shimada M, et al. Expression of desmoglein-I cell-adhesion molecule in primary tumors and metastatic lymph-nodes of esophageal cancer. Int J Oncol 1995;6:345-8.
150. [150] Natsugoe S, Aikou T, Shimada M, et al. Expression of desmoglein-I in squamous-cell carcinoma of the esophagus. J Sur Oncol 1994;57:105-10.
151. [151] Imai K, Kumagai S, Nakagawa K, et al. Immunolocalization of desmoglein and intermediate filaments in human oral squamous-cell carcinomas. Head Neck J Sci Special Head Neck 1995;17:204-12.
152. [152] Conn IG, Vilela MJ, Garrod DR, et al. Immunohistochemical staining with monoclonal antibody-32-2b to desmosomal glycoprotein-1 - its role in the histological assessment of urothelial carcinomas. Br J Urol 1990;65:176-80.
153. [153] Harada T, Shinohara M, Nakamura S, Shimada M, Oka M. Immunohistochemical detection of desmosomes in oral squamous-cell carcinomas - correlation with differentiation, mode of invasion, and metastatic potential. Int J Oral Maxillofacial Surg 1992;21:346-9.
154. [154] Jiang WG, Singhrao SK, Hiscox S, et al. Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clin Exp Metastasis 1997;15:593-602.
155. [155] Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 1985;26:1015.
156. [156] Hatala MA, Rayburn J, Rose DP. Comparison of linoleic acid and eicosapentaenoic acid incorporation into human breast cancer cells. Lipids 1994;29:831.
157. [157] Ferguson MAJ, Williams AF. Cell surface anchoring of proteins via glysyl-phosphatidyl-inositol structure. Ann Rev Biochem 1988;57:285.
158. [158] Williams CM, Maunder K. The influence of dietary fatty acid composition on N-ethyl-N-nitrosourea-induced mammary tumor incidence in the rat and on the composition of inositoland ethanol-amine-phospholipids of normal and tumor mammary tissue. Br J Nutr 1994;71:543.
159. [159] King ME, Spector AA. Effect of specific fatty acyl enrichment on membrane physical properties detected with a spin label probe. J Biol Chem 1978;253:6493.
160. [160] Burns CP, Luttenegger DG, Dudley DT, et al. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells. Cancer Res 1979;39:1726.
161. [161] Tween M, Uauy RD, Jameson DM, et al. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys 1992;294:564.
162. [162] Burns CP, Spector AA. Membrane fatty acids modification in tumour cells: a potential therapeutic adjunct. Lipids 1987;22:178-84.
163. [163] Lu L, Okada N, Nakatani S, Yoshikawa K. Eicosapentaenoic acid induced changes in membrane fluidity and cell adhesion molecules in cultured human keratinocytes. Br J Dermatol 1995;133:217.
164. [164] Salyer JL, Bohnsack JF, Knape WA. Mechanisms of tumour necrosis factor a alteration of PMN adhesion and migration. Am J Pathol 1990;136:831.
165. [165] Hanks SK, Calalb MB, Harper MC, et al. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 1992;89:8487-91.
166. [166] Schaller MD, Parsons JT. Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6:705-10.
167. [167] Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signalling. Annu Rev Cell Biol 1996;12:463-519.
168. [168] Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993;342:1024-5.
169. [169] BenZeev A. Cytoskeletal and adhesion proteins as tumor suppressors. Curr Opin Cell Biol 1997;9:99-108.
170. [170] Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996;8:724-30.
171. [171] Malik RK, Parsons JT. Integrin-mediated signalling in normal and malignant-cells - a role of protein-tyrosine kinases. Biochim Biophys Acta 1996;1287:73-6.
172. [172] Glukhova M, Koteliansky V, Sastre X, Thiery JP. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 1995;146:706-16.
173. [173] Furukawa T, Watanabe M, Kumota T, et al. Significance of in vitro attachment of human colon cancer to extracellular matrix proteins in experimental and clinical liver metastasis. J Surg Oncol 1993;53:10-6.
174. [174] Giancotti FG, Mainiero F. Integrin mediated adhesion and signlling in tumorigenesis. Biochim Biophys Acta 1994;1198:47-64.
175. [175] Rankin S, Morii N, Narumiya S, Rozengurt E. Botulinum C3 exoenzyme blocks the tyrosine phosphorylation of p125FAK and paxillin induced by bombesin and endothelin. FEBS Lett 1994;354:315-9.
176. [176] Seufferlein T, Rozengurt E. Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J Biol Chem 1994;269:27610-7.
177. [177] Johanning GL. Modulation of breast cancer cell adhesion by unsaturated fatty acids. Nutrition 1996;12:810-6.
178. [178] Rose DP, Connolly JM, Rayburn J, Coleman M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast-cancer cells in nude-mice. J Natl Cancer Inst 1995;87:587-92.
179. [179] Hubbard NE, Erickson KL. Effect of dietary linoleic acid level on lodgement, proliferation and survival of mammary tumor metastases. Cancer Lett 1989;44:117.
180. [180] Rose DP, Connolly JM, Meschter CL. Effect of dietary-fat on human breast-cancer growth and lung metastasis in nude-mice. J Natl Cancer Inst 1991;83:1491-5.
181. [181] Jiang WG, Hiscox S, Puntis MCA, et al. Linolenic acid (GLA) inhibits tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and tumour cell-matrix interaction. Int J Oncol 1996;8:583-7.
182. [182] Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
183. [183] Frisch SM, Vuori K, Ruoslahti E, Chanhui PY. Control of adhesion-dependent cell - survival by focal adhesion kinase. J Cell Biol 1996;134:793-9.
184. [184] Seegers JC, deKock M, Lottering ML, et al. Effects of γ-linolenic acid and arachidonic acid on cell cycle progression and apoptosis induction in normal and transformed cells. Prostaglandins Leukotrienes Essent Fatty Acids 1997;56:271-80.
185. [185] Assoian RK, Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progress. Curr Opin Cell Biol 1997;9:93-8.
186. [186] Kariko D, Rosenbaum H, Kuo A, et al. Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor I mRNA in cultured human endothelial cells. FEBS Lett 1995;361:118-22.
187. [187] Reich R, Royce L, Martin GR. Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells. Biochem Biophys Res Commun 1989;160:559-64.
188. [188] Zou Z, Anisowicz A, Hendrix MJC, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-9.
189. [189] Hopkins PCR, Whisstock J, Sager R. Function of maspin. Science 1994;265:1893-4.
190. [190] Zhang M, Maass N, Magit D, Sager R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 1997;8:179-86.
191. [191] Sheng S, Carey J, Seftor EA, et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996;93:11669-74.
192. [192] Jiang WG, Hiscox S, Horrobin DF, et al. Expression of maspin in cancer cells and its regulation by γ-linolenic acid. Biochem Biophys Res Commun 1997;237:639-44.
193. [193] Liu XH, Rose DP. Suppression of type-IV collagenase in MDA-MB-435 human breast-cancer cells by eicosapentaenoic acid in-vitro and in-vivo. Cancer Lett 1995;92:21-6.
194. [194] Giavazzi R, Fopplo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993;92:3038.
195. [195] Byers SW, Sommers CL, Hoxter B, et al. Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength. J Cell Sci 1995;108:2053.
196. [196] Jiang WG. In vitro models of cancer invasion and metastasis: recent developments. Eur J Surg Oncol 1994;20:493-9.
197. [197] Lauri D, Martin-Padura I, et al. Role of J1 integins in tumor cell adhesion to cultured human endothelial cell. Lab Invest 1991;65:525.
198. [198] Lauri D, Needham L, Martin-Padur I, Dejana E. Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Nat Cancer Inst 1991;63:1321.
199. [199] Piali L, Fichtel A, Terpe HJ, et al. Endothelial vascular cell adhesion molecule 1 expression as suppressed by melanoma and carcinoma. J Exp Med 1995;181:811.
200. [200] Shapiro L, Fanno AM, Kwong PD. Structural basis of cell-cell adhesion by cadherins. Nature 1995;375:327.
201. [201] Offner FA, Schiefer J, Wirtz HC, et al. Tumor-cell-endothelial interactions-free-radicals are mediators of melanoma-induced endothelial-cell damage. Virchows Arch Int J Path 1996;428:99.
202. [202] Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor a. Arterioscler Thromb Vasc Biol 1995;15:622.
203. [203] De Caterina R, Cybulsky MI, Clinton SK, et al. The ω-3 fatty acid docosahexaenoate reduces cytokine induced expression of proatherogenic and proinflammatory proteins in human endothelail cells. Atheroscler Thromb 1829;14:1994.
204. [204] De Caterina R, Cybulsky MA, Clinton SK, et al. ω-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:191-5.
205. [205] Jiang WG, Bryce RP, Horrobin DF, Mansel RE. Linolenic acid regulates gap junction communications in endothelial cells and their interaction with tumour cells. Prostaglandins Leukotrienes Essent Fatty Acids 1997;56:307-16.
206. [206] Hii CST, Ferrante A, Schmidt S, et al. Inhibition of gap junctional communication by polyunsaturated fatty-acids in WB cells - evidence that connexin-43 is not hyperphosphorylated. Carcinogenesis 1996;16:1505-11.
207. [207] Jiang WG, Hallett MB, Puntis MCA. Motility factors in cancer invasion and metastasis. Surg Res Commun 1994;16:219-37.
208. [208] Schiffmann E. Motility as a principal requirement for metastasis. Cancer Invest 1990;8:673-4.
209. [209] Kanayasutoyoda T, Morita I, Murota S. Docosapentaenoic acid (22/5, n-3), an elongation metabolite of eicosapentaenoic acid (20/5, n-3), is a potent stimulator of endothelial-cell migration on pretreatment in-vitro. Prostaglandins Leukotrienes Essent Fatty Acids 1996;54:319-25.
210. [210] Jiang WG. Membrane ruffling of cancer cells: A parameter of tumour cell motility and invasion. Eur J Surg Oncol 1995;21:307-9.
211. [211] Jiang WG, Hiscox S. Hepatocyte growth factor and c-met, a cytokine playing multiple and converse roles. Histol Histopathol 1997;12:537-55.
212. [212] Folkman J, Weisz PB, Jouille MM, et al. Control angiogenesis with synthetic heparin substitute. Science 1989;243:1490-3.
213. [213] Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
214. [214] Folkman J. The influence of angiogenesis research on management of patients with breast-cancer. Breast Cancer Res Treat 1995;36:109-18.
215. [215] Brem H, Ingber D, Blood CH, et al. Suppression of tumor metastasis by angiogenesis inhibition. Surg Forum 1991;42:439-41.
216. [216] Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
217. [217] Hennig B, Lipke D, Boissonneault G, Ramasamy S. Role of fatty-acids and eicosanoids in modulating proteoglycan metabolism in endothelial-cells. Prostaglandins Leukotrienes Essent Fatty Acids 1995;53:315-24.
218. [218] McCarty MF. Fish-oil may impede tumor angiogenesis and invasiveness by down-regulating protein-kinase-c and modulating eicosanoid production. Med Hypotheses 1996;46:107-11.
219. [219] Cai J, Jiang WG, Mansel RE. Inhibition of vascular endothelial cell motility and angiogenesis by γ-linolenic acid. Prostaglandins Leukotrienes Essent Fatty Acids 1997;57:247.
220. [220] Trochon V, Mabilat C, Bertrand P, et al. Evidence of involvement of CD44 in endothelial-cell proliferation, migration and angiogenesis in-vitro. Int J Cancer 1996;66:664-8.
221. [221] Ormerod LD, Garsd A, Abelson MD, et al. Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Am J Pathol 1990;137:1243-52.
222. [222] Kanayasu T, Morita I, Nakao-Hayashi J, et al. Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipid 1991;26:271-6.
223. [223] Ito K, Abe T, Tomita M, et al. Anti-angiogenic activity of arachidonic-acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial-cells and neovascularization in mice. Int J Cancer 1993;55:660-6.
224. [224] Venkatraman JT, Chandrasekar B, Weintraub ST, Fernandes G. Differential-effects of ω-6 and ω-3-fatty-acids on interleukin-2 production and messenger-RNA expression by EL-4 IL-2 cells. J Nutr Biochem 1995;6:467-73.
225. [225] Purasiri P, Murray A, Richardson S, et al. Modulation of cytokine production in-vivo by dietary essential fatty-acids in patients with colorectal-cancer. Clin Sci 1994;87:711-7.
226. [226] Wigmore SJ, Fearon KCH, Ross JA. Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids. Ann Surgery 1997;225:103-11.
227. [227] Ohata T, Fukuda K, Takahashi M, et al. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by ω-3 polyunsaturated fatty acids. Jpn J Cancer Res 1997;88:234-7.
228. [228] Jiang WG, Hiscox S, Hallett MB, et al. Regulation of motility and invasion of cancer cells by human monocytes. Anticancer Res 1995;15:1303-10.
229. [229] Purasiri P, Ashby J, Keys SD, et al. Effect of essential fatty-acids on circulating T-cell subsets in patients with colorectal-cancer. Cancer Immunol Immunother 1996;73:36-43.
230. [230] Rose DP, Connolly JM, Coleman M. Effect of ω-3-fatty-acids on the progression of metastases after the surgical excision of human breast-cancer cell solid tumors growing in nude-mice. Clin Cancer Res 1996;2:1751-6.
231. [231] Rose DP, Hatala MA, Connolly JM, Rayburn J. Effect of diets containing different levels of linoleic-acid on human breast-cancer growth and lung metastasis in nude-mice. Cancer Res 1993;53:4686-90.
232. [232] Maehle L, Eilertsen E, Mollerup S, et al. Effects of n-3 fatty-acids during neoplastic progression and comparison of in-vitro and in-vivo sensitivity of two human tumor-cell lines. Br J Cancer 1995;71:691-6.
233. [233] Jiang WG, Puntis MCA, Horrobin DF, et al. Inhibition of neutrophil respiratory burst and cytokine priming by γ-linolenic acid. Br J Surg 1996;83:659-64.
234. [234] Perkins DM, Duncan JR. The effect of γ-linolenic acid and zinc supplementation on the growth of normal and tumor-cells in vitro. Prostaglandins Leukotrienes Essent Fatty Acids 1991;43:43-8.
235. [235] Bougnoux P, Chajes V, Lanson M, et al. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 1991;20:185-94.
236. [236] Bougnoux P, Koscielny S, Chajes V, et al. Linolenic acid content of adipose breast-tissue - a host determinant of the risk of early metastasis in breast-cancer. Br J Cancer 1994;70:330-4.
237. [237] Lanson M, Bougnoux P, Besson P, et al. n-6 polyunsaturated fatty acids in human breast carcinoma phophatidylethanolamine and early relapse. Br J Cancer 1990;61:776-8.
238. [238] Narayan P, Dahiya R. Alterations in sphingomyelin and fatty-acids in human benign prostatic hyperplasia and prostatic-cancer. Biomed Biochim Acta 1991;50:1099-108.
239. [239] Fernandezbanares F, Esteve M, Navarro E, et al. Changes of the mucosal n3 and n6 fatty-acid status occur early in the colorectal adenoma-carcinoma sequence. Gut 1996;38:254-9.
240. [240] Chaudry A, Mcclinton S, Moffat LEF, Wahle KWJ. Essential fatty-acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer 1991;64:1157-60.
241. [241] Chaudry AA, Wahle KWJ, Mcclinton S, Moffat LEF. Arachidonic-acid metabolism in benign and malignant prostatic tissue in-vitro - effects of fatty-acids and cyclooxygenase inhibitors. Int J Cancer 1994;57:176-80.
242. [242] Engan T, Bjerve KS, Hoe AL, Krane J. Characterization of plasma-lipids in patients with malignant disease by c-13 nuclear-magnetic-resonance spectroscopy and gas-liquid-chromatography. Blood 1995;85:1323-30.
243. [243] Pandey M, Khatri AK, Dubey SS, et al. Erythrocyte-membrane fatty-acid profile in patients with primary-carcinoma of the gallbladder. J Surg Oncol 1995;59:31-4.
244. [244] Prisco D, Paniccia R, Coppo M, et al. Platelet activation and platelet lipid-composition in pulmonary-cancer. Prostaglandins Leukotrienes Essent Fatty Acids 1995;53:65-8.
245. [245] Neoptolemos JP, Husband D, Imray C, et al. Arachidonic-acid and docosahexaenoic acid are increased in human colorectal-cancer. Gut 1991;32:278-81.
246. [246] Reynier M, Sari H, Danglebermes M, et al. Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonie cells. Cancer Res 1991;51:1270-7.
247. [247] Sakai K, Okuyama H, Yura J, et al. Composition and turnover of phospholipids and neutral lipids in human breast-cancer and reference tissues. Carcinogenesis 1992;13:579-84.
248. [248] Fox JC, Hay RV. Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH777 rat hepatoma cultures. Biochem J 1992;286:305-12.
249. [249] Ikushima S, Fujiwara F, Todo S, Imashuku S. Effects of polyunsaturated fatty-acids on vincristine-resistance in human neuroblastoma-cells. Anticancer Res 1991;11:1215-20.
250. [250] Nakazawa I, Iwaizumi M, Ohuchi K. A difference in prostaglandin-producing ability between cancer-cells metastasized into liver and kidney. Tohoku J Exp Med 1991;165:299-304.
251. [251] Nakazawa I, Iwaizumi M, Ohuchi K. Some features of prostaglandin synthesis of the cancer-cells metastasized into liver from gastric-cancer lesions. Tohoku J Exp Med 1993;170:59-61.
252. [252] Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon-cancer. J Lab Clin Med 1993;122:518-23.
253. [253] Cantrill RC, Ells GW, Deantueno RJ, et al. The effect of n-6 fatty-acids on normal and v-ki ras transformed NIH-3T3 cells. Anticancer Res 1992;12:2197-202.
254. [254] Shimizu S, Yamane M, Abe A, et al. Hydroxylation of docosahexaenoic acid or arachidonic-acid in human colonie well-differentiated adenocarcinoma homogenate. Biochim Biphys Acta 1995;1256:293-6.
255. [255] Shimakura S, Boland CR. Eicosanoid production by the human gastric-cancer cell-line AGS and its relation to cell-growth. Cancer Res 1992;52:1744-9.
256. [256] Horrobin DF. DNA-protein and membrane-lipid-competing paradigms in biomedical-research. Med Hypotheses 1995;44:229-32.
257. [257] Horrobin DF. The philosophical basis of drug target selection. Pharm Med 1996;10:29-42.
258. [258] Earashi M, Noguchi M, Tanaka M. In-vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic-acid on MDA-MB-231 human breast-cancer. Breast Cancer Res Treat 1995;37:29-37.
259. [259] Noguchi M, Earashi M, Minami M, et al. Effects of piroxicam and esculetin on the MDA-MB-231 human breast-cancer cell-line. Prostaglandins Leukotrienes Essent Fatty Acids 1995;53:325-9.
260. [260] Noguchi M, Earashi M, Miyazaki I, et al. Effects of indomethacin with or without linoleic-acid on human breast-cancer cells in-vitro. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:381-6.
261. [261] Noguchi M, Earashi M, Minami M, et al. Effects of eicosapentaenoic and docosahexaenoic acid on cell-growth and prostaglandin-E and leukotriene-B production by a human breast-cancer cell-line (MDA-MB-231). Oncology 1995;52:458-64.
262. [262] Hussey HJ, Tisdale MJ. Inhibition of tumor-growth by lipoxygenase inhibitors. Br J Cancer 1996;74:683-7.
263. [263] Quoc KP, Pascaud M. Effects of dietary γ-linolenic acid on the tissue phospholipid fatty-acid composition and the synthesis of eicosanoids in rats. Ann Nutr Metab 1996;40:99-108.
264. [264] Ekmekci A, Sayli A, Donmez H, Bal F. In-vitro effects of prostaglandin-E1 and indomethacin on mitomycin c-induced sister-chromatid exchanges in mitogen-stimulated humanlymphocytes. Mutat Res 1995;328:49-53.
265. [265] Kahky MP, Lind DS, Cruz AB, Gaskill HV. Prostaglandin-E1 enhances tumoricidal activity of 5-fluoro-2′-deoxyuridine in rats. J Surg Res 1991;51:119-23.
266. [266] Lawson JA, Adams WJ, Morris DL. The effect of misoprostol on colon-cancer. Aust New Zealand J Surg 1994;64:197-201.
267. [267] Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein-turnover. Cancer Res 1991;51:6089-93.
268. [268] Kakizoe S, Kakizoe K, Kakizoe Y, et al. Chemolipiodolization and prostaglandin-E1 administration with use of hepatic arterial infusion port for the treatment of hepatocellular-carcinoma and liver-cirrhosis. Hepato-Gastroenterology 1996;43:1377-82.
269. [269] Vonarxcoinsmann V, Foultier MT, Patrice T, et al. Modulation of rat colon-cancer cell adhesiveness by PGE1 analog misoprostol or indomethacin. Cancer J 1993;6:229-34.
270. [270] Mengeaud V, Nano J, Fournel S, Rampal P. Effects of eicosapentaenoic acid, γ-linolenic acid and prostaglandin-E1 on 3 human colon-carcinoma cell-lines. Prostaglandins Leukotrienes Essent Fatty Acids 1992;47:313-9.
271. [271] Ells GW, Chisholm KA, MacDougall PS, et al. Relationship between fatty acid desaturation in tumor cell lines and sensitivity to the cytotoxic effects of γ-linolenic acid. Proc Am Assoc Cancer Res 1997;38:62.
272. [272] Sumida C, Vellette G, Numez EA. Interaction of unsaturated fatty acids with rat liver glucocorticoid receptors: studies to localize the site of interaction. Acta Endocrinol 1993;129:348-55.
273. [273] Sumida C. Fatty acids, ancestral ligands and modern co-regulators of the steroid hormone receptor cell signalling pathway. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:137-44.
274. [274] Nunez EA. Free fatty acids as modulators of the steroid hormone message. Prostaglandins Leukotrienes Essent Fatty Acids 1993;48:63-70.
275. [275] Vellette F, Vanet A, Sumida C, Nunez EA. Modulatory effects of unsaturated fatty acids with rat liver glucocorticoid receptors. Endocrinology 1991;129:1363-9.
276. [276] Blobe GC, Khan WA, Hannun YA. Protein kinase C: cellular target of the second messenger arachidonic acid? Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:129-35.
277. [277] Bandyopadhyay GK, Imagawa W, Nandi S. Role of GTP binding proteins in the polyunsaturated fatty acid stimulated proliferation of mouse mammary epithelial cells. Prostaglandins Leukotrienes Essent Fatty Acids 1995;52:151-8.
278. [278] Montgomery RB, Stahl WL. Fatty acid and phospholipid stimulation of protein phosphorylation in fibroblasts and tumour cell lines. Proc Am Assoc Cancer Res 1997;38:62.
279. [279] Krey G, Braissant OL, Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997;11:779-91.
280. [280] Camp HS, Tafuri SR. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J Biol Chem 1997;272:10811-6.
281. [281] Awad AB, Ntanios FY, Fink CS, et al. Effect of membrane lipid alteration on the growth, phospholipase C activity and G protein of HT-29 tumor cells. Prostaglandins Leukotrienes Essent Fatty Acids 1996;55:293-302.
282. [282] Adams M, Reginato MJ, Shao D, et al. Transcriptional activation by peroxisome proliferator activated receptor g is inhibitied by phosphorylation at a consensus mitogen activated protein kinase site. J Biol Chem 1997;272:2128-32.
283. [283] Rao GN, Alexander RW, Runge MS. Stimulate c-fos, c-jun, and c-myc messenger-RNA expression, mitogen-activated protein-kinase activation, and growth in rat aortic smooth-muscle cells. J Clin Invest 1995;96:842-7.
284. [284] Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 1997;94:3771-6.
285. [285] Burns CP, Wagner BA. Effects of exogenous lipids on cancer and cancer chemotherapy. Drug Saf 1993;8:57-68.
286. [286] Baronzio GF, Solbiati L, Ierace T, et al. Adjuvant therapy with essential fatty-acids (EFAs) for primary liver tumors. Med Hypotheses 1995;44:149-55.
287. [287] Das UN, Prasad VVSK, Reddy DR. Local application of γ-linolenic acid in the treatment of human gliomas. Cancer Lett 1995;94:147-55.
288. [288] Vandermerwe CF, Booyens J, Katzeff IE. Oral γ-linolenic acid in 21 patients with untreatable malignancy - an ongoing pilot open clinical-trial. Br J Clin Pract 1987;41:907-15.
289. [289] Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast-cancer in high-risk patients supplemented with nutritional antioxidants, essential patty acids and coenzyme q(10). Mol Asp Med 1994;15:231-40.
290. [290] Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty-acids on the progress of cachexia in patients with pancreatic-cancer. Nutrition 1996;12:27-30.
291. [291] Anti M, Armelao F, Marra G, et al. Effects of different doses of fish-oil on rectal cell-proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-18.
292. [292] McIllmurray MB, Turkie W. Controlled trial of γ-linolenic acid in Dukes's colorectal cancer. Br Med J 1987;294:1260.
293. [293] Vandermerwe CF, Booyens J. Essential fatty-acids and their metabolic intermediates as cytostatic agents - the use of evening primrose oil (linoleic and γ-linolenic acid) in primary liver-cancer - a double-blind placebo controlled trial. S Afr Med J 1987;72:79.
294. [294] Vandermerwe CF, Booyens J, Joubert HF, et al. The effect of γ-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver-cancer - a double-blind placebo controlled trial. Prostaglandins 1990;40:199-202.
295. [295] Ohira T, Nishio K, Ohe Y, et al. Improvement by eicosanoids in cancer cachexia induced by LLC-IL-6 transplantation. J Cancer Res Clin Oncol 1996;122:711-5.
296. [296] Eynard AR, Manzur T, Moyano A, et al. Dietary deficiency or enrichment of essential fatty acids modulates tumorigenesis in the whole body of cobalt-60-irradiated mice. Prostaglandins Leukotrienes Essent Fatty Acids 1997;56:239-44.
297. [297] Horrobin DF. High-levels of polyunsaturated fat may inhibit cancer growth. Br Med J 1996;312:511.
298. [298] Lhuillery C, Cognault S, Germain E, et al. Suppression of the promoter effect of polyunsaturated fatty acids by the absence of dietary vitamin E in experimental mammary carcinoma. Cancer Lett 1997;114:233-4.
299. [299] Narisawa T, Fukaura Y, Yazawa K, et al. Colon-cancer prevention with a small amount of dietary perilla oil high in α-linolenic acid in an animal-model. Cancer 1994;73:2069-75.
300. [300] Fukui H, Akiyoshi K, Sunamoto J. O/W-emulsion of α-linolenic acid stabilized with hydrophobized polysaccharide - its effect on the growth of human colon-cancer cells. J Biomater Sci 1996;7:829-38.
301. [301] Prentice RL, Sheppard L. Dietary fat and cancer. Consistency of the epidemiologic data and disease prevention that may follow from a practical reduction in fat consumption. Cancer Cause Control 1990;1:81-97.
302. [302] Sasaki S, Horacsek M, Kesteloot H. An ecological study of the relationship between dietary fat intake and breast cancer motility. Prev Med 1993;22:187-202.
303. [303] Bakker N, van't Veer P, Zick PL, et al. Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. Int J Cancer 1997;72:587-91.
304. [304] London SJ, Sacks FM, Stampfer MJ, et al. Fatty acid composition of the subcutaneous adipose tissue and risk of proliferation in benign breast disease and breast cancer. J Natl Cancer Inst 1993;85:785-93.
305. [305] Petrek JA, Hudgins LC, Levine B, et al. Breast cancer risk and fatty acids in the breast and abdominal adipose tissues. J Natl Cancer Inst 1994;86:53-6.
306. [306] Liu B, Maher RJ, Hannun YA, et al. 12(s)-HETE enhancement of prostate tumor-cell invasion-selective role of PKC-α. J Natl Cancer Inst 1994;86:1145-51.
307. [307] Liu XH, Connolly JM, Rose DP. The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and ω-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice. Cancer Lett 1996;109:223-30.
308. [308] Tang DG, Diglio CA, Honn KV. Activation of microvascular endothelium by eicosanoid 12(s)-hydroxyeicosatetraenoic acid leads to enhanced tumor-cell adhesion via up-regulation of surface expression of α-v-β-3 integrin - a posttranscriptional, protein-kinase c-dependent and cytoskeleton-dependent process. Cancer Res 1994;54:1119-29.
309. [309] Honn KV, Tang DG, Grossi I, et al. Tumor cell-derived 12(s)-hydroxyeicosatetraenoic acid induces microvascular endothelial-cell retraction. Cancer Res 1994;54:565-74.
310. [310] Silverman AL, Bronstein JC, Krymgold S, et al. Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies. Cancer Epidemiol Biomarkers Prev 1996;5:53-6.
311. [311] Gao X, Grignon DJ, Chbihi T, et al. Elevated 12-lipoxygenase messenger-RNA expression correlates with advanced-stage and poor differentiation of human prostate-cancer. Urology 1995;46:227-37.
312. [312] Schoonjans K, Peinadoonsurbe J, Lefebvre AM, et al. PPAR-a and PPAR-g activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein-lipase gene. EMBO J 1996;19:5336-48.
313. [313] Varanasi U, Chu RY, Huang Q, et al. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl-coenzyme-A oxidase gene. J Biol Chem 1996;271:2147-55.
314. [314] Palmer CNA, Hsu MH, Griffin KH. Novel sequence determinants in peroxisome proliferator signalling. J Biol Chem 1995;270:16114-21.
315. [315] Tsukita S, Itoh M, Nagafuchi A, et al. Submembranous junctional plaque proteins include potential tumor-suppressor molecules. J Cell Biol 1993;123:1049-53.
316. [316] Yin CY, Knudson CM, Korsmeyer SJ, et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997;385:637-40.
317. [317] Hockenbery DM. Bcl-2 in cancer development and apoptosis. J Cell Sci 1994;S18:51-5.
318. [318] Symons M. The rac and rho pathways as a source of drug targets for ras-mediated malignancies. Curr Opin Biotechnol 1995;6:674-88.
319. [319] Demarco AV, Cantrill RC, Patterson P, Horrobin DF. Treatment of cells with polyunsaturated fatty-acids alters the composition of inositol phosphoglycerides available for transmembrane signaling. J Cell Biochem 1994;S18D:30.